Navigation Links
IDM Pharma Reports Third Quarter 2007 Financial Results
Date:11/8/2007

ions as planned, including any further clinical trials of any of the Company's product candidates; whether any steps taken by the Company to contain costs will in fact result in sufficient reduction in expenses; reliance on key employees, especially senior management; the risk that the Company may not secure or maintain relationships with collaborators, and the Company's dependence on intellectual property. These factors are more fully discussed in the Company's Quarterly Report on Form 10-Q filed with the SEC for the quarter ended June 30, 2007 and other periodic reports filed with the SEC. The Company expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law."

IDM PHARMA, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

Three months ended Nine months ended

September 30, September 30,

2007 2006 2007 2006

Revenues:

Research grants and

contract revenue $- $- $55,000 $68,000

Related party

revenue 3,113,000 3,012,000 8,994,000 8,228,000

License fees,

milestones and

other revenues 10,000 16,000 30,000 32,000

Total revenues 3,123,000 3,028,000 9,079,000 8,328,000

Costs and expenses:

Research and

development 6,377,000 5,271,000 17,032,000 17,032,000

Impairment of

assets 52,000 144,000 95,000 497,000

Selling and

marketing 246,000 234,000 448,000 397,000

General and

administrative 2,477,000 1,563,000 9,216,000 6,817,000

Acquired
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website ... navigation. The most notable change is the responsive web design. Website users will now ... can easily submit quote requests for sod, sign-up for the monthly turf-tips email, and ...
(Date:8/28/2015)... ... 2015 , ... Where can successful, well educated, or attractive ... up to help quality singles find dating partners or ideal matches. , ... well educated, or attractive. , It updates profiles under the category of " ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... medicine through health promotion and disease prevention, improving a patient’s quality of life ... in the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and others. A ...
(Date:8/27/2015)... ... August 28, 2015 , ... Shortening the school ... performance in mathematics, according to researchers at Georgia State University and Montana State ... July, analyzed the impact of a four-day school week on student achievement by ...
Breaking Medicine News(10 mins):Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 2Health News:MillionaireMatchmakerOnline.net Collects and Updates Newest Millionaire and Quality Single Profiles on the Page of Millionaire Matchmaker Online Canada. 3Health News:Health Clinic Opening and Public Art Unveiling 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 2Health News:Four-Day School Week Can Improve Academic Performance, Study Finds 3
... Honor of Huggies, 30th Anniversary, 30 Real Moms to be Featured ... ... of moms is,different from generations of the past. Strict definitions of ... their,roles on their terms. To celebrate its 30th anniversary, the Huggies ...
... today announced the launch of its superfast, low memory usage secure ... the PDF specs and is believed to be the smallest and ... ... 3, 2008 -- Drumlin Security (http://www.drumlinsecurity.co.uk) today announced the launch of ...
... Security as a,Service Provider (SaaS), announced today that ... Security Standard (DSS) version 1.2,released Oct. 1st by ... revised standard provides clarification and changes intended,to help ... is a Qualified Security Assessor Company (QSAC) and ...
... lives with at least one disability, CDC says , , THURSDAY, ... -- one in five people -- have some type of ... Prevention. , And a new CDC study finds that black, ... poor health at disproportionately higher rates than white or Asian ...
... The Association of,Clinical Research Organizations (ACRO) ... inaugural Clinical Outsourcing Leaders Summit with a ... research executives,November 13, 2008 in Washington, DC., ... interactive discussions,surrounding the impact of the presidential ...
... Weston Medical Publishing today,announced publication ... of Neurodegeneration,and Regeneration. (ISSN 1932-1481) This ... all aspects of neurodegeneration, neuroprotection and,neuroregeneration ... their relevance in treating neurodegenerative disorders ...
Cached Medicine News:Health News:Generation Huggies Celebrates 30 Years With 30 Moms 2Health News:Generation Huggies Celebrates 30 Years With 30 Moms 3Health News:SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2 2Health News:SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2 3Health News:SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2 4Health News:SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2 5Health News:SecureWorks Provides Solutions to Help with Payment Card Industry (PCI) Data Security Standard (DSS) Version 1.2 6Health News:Minorities With Disabilities Report Poorer Health 2Health News:Clinical Outsourcing Leaders Summit Set to Convene November 13 2Health News:New Journal to Explore Neurodegenerative, Neuroprotective and Euroregenerative Therapies! 2
(Date:8/28/2015)... August 28, 2015 The scientific team ... with one of the leading academics in the field of ... record holder in life extension for model animals - 10 ... of aging and age-related diseases, primarily, around the stability and ... just been published as "Stability analysis of a model gene ...
(Date:8/28/2015)... PITTSBURGH , Aug. 28, 2015 /PRNewswire/ ... that its shareholders have approved Mylan,s proposed acquisition ... TASE) and the related issuance of Mylan ordinary ... meeting of shareholders held today. The transaction received ... extraordinary general meeting. In addition, the transaction received ...
(Date:8/28/2015)... 2015 The global mHealth ... billion by 2020, growing at a CAGR of 47.6% ... by Grand View Research, Inc. Monitoring services is expected ... 2014 to 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ... rising incidences of chronic diseases such as cancer, heart ...
Breaking Medicine Technology:Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 2Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 3Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 4Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 5Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 6Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 7Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 8Mylan Shareholders Overwhelmingly Approve Proposed Acquisition of Perrigo 9mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5
... CAMBRIDGE, England, May 28, 2012 Acacia ... of APD421, in the prevention of post-operative nausea & ... the incidence of nausea and vomiting compared to placebo ... PONV. Vomiting and especially nausea remain a major problem ...
... La., May 25, 2012   Albemarle Corporation (NYSE: ... marketer of highly engineered specialty chemicals, announced today that ... ibuprofen by an estimated 15% effective immediately, or as ... ) Albemarle,s ibuprofen and other generic active ...
Cached Medicine Technology:Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 2Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 3Acacia Pharma Announces Excellent Phase II Results for APD421 in Post-Operative Nausea & Vomiting (PONV) 4Albemarle to increase ibuprofen prices 2Albemarle to increase ibuprofen prices 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: